Skip to main content

Immunology focus areas

Our experience, paired with an innate hunger for exploration, drives cutting-edge research across three key disease areas – rheumatology, dermatology and gastroenterology.

Let's change lives

Our deep expertise in immunology is rooted in more than two decades of world-class science and an unwavering commitment to innovation. The patient inspires our every step. Their needs fuel our passion. And as we advance research, we aim to bring to life our vision of reducing the burden for all those touched by immune-mediated diseases.


AbbVie has been devoted to transforming therapy for diseases affecting joints, muscles and ligaments for over 20 years. With high medical need still present in the field, we’re committed to delivering solutions for patients.

Learn more


For more than a decade, AbbVie has been striving to uncover new answers and improve the standard of care for patients facing immune-mediated skin diseases. Our pursuit has led to exciting discoveries and the opportunity to deliver treatments in areas of high unmet medical need for patients.

Learn more


We have been advancing the standard of care in inflammatory bowel disease (IBD) for over 10 years. With our commitment to research and development in the field, we aim to create an even brighter future for patients with disorders of the stomach and intestines.

Learn more

Where to find AbbVie's Immunology Team

March 25-29, 2022:
AAD American Academy of Dermatology

April 9-11, 2022:
RAD Revolutionizing Atopic Dermatitis Conference

April 24-28, 2022:
ACR American College of Rheumatology Annual Meeting

May 21-24, 2022:
DDW Digestive Disease Week

June 1-4, 2022:
EULAR European Congress of Rheumatology

September 7-11, 2022:
EADV European Academy of Dermatology and Venerology Congress

October 8-11, 2022:
UEGW United European Gastroenterology Week

October 17-19, 2022:
ISAD International Society of Atopic Dermatitis Meeting

Watch: Personalized Medicine in Immune-Mediated Diseases

Lisa Olson, vice president, discovery, Immunology Site Head, Worcester, sat down with Stacy Van Epps, Ph.D., senior scientist, medicinal chemistry, Worcester, to discuss how personalized medicine and new discoveries are accelerating progress in immune-mediated diseases.

Watch the video

Lisa Olson, VP of Immunolgoy Research at AbbVie sitting in chair and speaking to woman

Lisa Olson, vice president, discovery, Immunology Site Head, Worcester with Stacy Van Epps, Ph.D., senior scientist, medicinal chemistry, Worcester.